FDA Adverse Event Injury Summary report: N

SPRINT QUATTRO SECURE

MDR report key: 3507392 · Received December 9, 2013

Report

Report Number
2649622-2013-13788
Event Type
Injury
Date Received
December 9, 2013
Report Date
October 8, 2013
Manufacturer
MPRI
Product Code
LWS
PMA / PMN Number
P920015
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED OUTSIDE THE U.S. WHERE THE SAME MODEL IS DISTRIBUTED. ALL INFORMATION PROVIDED IS INCLUDED IN THIS REPORT. PATIENT INFORMATION IS NOT GENERALLY AVAILABLE DUE TO CONFIDENTIALITY CONCERNS. (B)(4).

Additional Manufacturer Narrative · 1

PRODUCT EVENT SUMMARY: THE LEAD WAS NOT RETURNED FOR ANALYSIS. HOWEVER, PERFORMANCE DATA COLLECTED FROM THE DEVICE WAS RECEIVED AND ANALYZED. ANALYSIS OF THE DEVICE MEMORY INDICATED THE IMPEDANCE ON THE RV (RIGHT VENTRICULAR) PACING LEAD WAS BEYOND THE EXPECTED UPPER RANGE, LEAD WARNING ALERT, AND OVERSENSING DUE TO NON-PHYSIOLOGIC SIGNALS/SIC (SENSING INTEGRITY COUNTER). 14733 VENTRICULAR-SIC OCCUR SINCE (B)(4) 2013. 47 NON-SUSTAINED TACHYCARDIA (NST) AND 5 VENTRICULAR FIBRILLATION (VF) EPISODES OF LESS THAN 220 MS VENTRICULAR TO VENTRICULAR CYCLES ARE RECORDED BETWEEN (B)(4) 2013. MAX VENTRICULAR PACE IMPEDANCE RISES FROM AN APPROXIMATELY BASELINE OF 700 OHM TO GREATER THAN 16000 OHM THE WEEK ENDING (B)(4) 2013. RV PACE LEAD IMPEDANCE ALERT OCCURRED ON (B)(4) 2013.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THERE WAS HIGH IMPEDANCE AND SHORT INTERVAL COUNTS (SIC) ON THE RIGHT VENTRICULAR (RV) LEAD. THE LEAD WAS CAPPED AND REPLACED. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
636022 SPRINT QUATTRO SECURE DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER LWS MPRI 6947

Patients

Seq Age Sex Outcome Treatment
1 00070 YR Hospitalization| R